PortfoliosLab logoPortfoliosLab logo

Janus Henderson Global Life Sciences Fund Class T (JAGLX) Alternatives

Janus Henderson Global Life Sciences Fund Class T (JAGLX) belongs to the Health & Biotech Equities category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with JAGLX. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.

Cheapest Alternatives to JAGLX

JAGLX charges 0.92% annually. Among mutual funds in the Health & Biotech Equities category, these options have the lowest expense ratios among JAGLX alternatives.


Best Risk-Adjusted Alternatives to JAGLX

Among mutual funds in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.


Top Performing JAGLX Alternatives (YTD)

JAGLX alternatives from the Health & Biotech Equities category, sorted by year-to-date return.


Lowest Volatility Alternatives to JAGLX

JAGLX alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.


Lowest Drawdown Alternatives to JAGLX

JAGLX alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.


Other Mutual Funds from Janus Henderson

Most popular Janus Henderson mutual funds on PortfoliosLab, across asset classes.


Often Compared With JAGLX

What investors most often compare with JAGLX, based on PortfoliosLab usage data.


Compare JAGLX with Any Fund or Stock

Compare JAGLX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.